Equities

ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)56.56
  • Today's Change0.70 / 1.25%
  • Shares traded24.18k
  • 1 Year change+9.38%
  • Beta0.7347
Data delayed at least 15 minutes, as of Nov 22 2024 16:48 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments22148100
Total Receivables, Net162169132
Total Inventory11110582
Prepaid expenses178.397.59
Other current assets, total8.0213--
Total current assets520344322
Property, plant & equipment, net454353
Goodwill, net282828
Intangibles, net209252294
Long term investments------
Note receivable - long term------
Other long term assets12112.21
Total assets904760772
LIABILITIES
Accounts payable372923
Accrued expenses583628
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.850.850.85
Other current liabilities, total503336
Total current liabilities1459988
Total long term debt285286287
Total debt286287287
Deferred income tax------
Minority interest------
Other liabilities, total173639
Total liabilities447422413
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital514404388
Retained earnings (accumulated deficit)(80)(97)(48)
Treasury stock - common(10)(5.09)(3.14)
Unrealized gain (loss)------
Other equity, total8.8612(3.06)
Total equity458339359
Total liabilities & shareholders' equity904760772
Total common shares outstanding201817
Treasury shares - common primary issue0.260.150.08
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.